Global threat of diabetes highlighted by WHO
The number of people with diabetes has nearly quadrupled since 1980, with an estimated 422 million people living with the condition across the world in 2014, says a WHO report.
Read MoreAuthor: Hugh Gosling
Anger at UK government’s “profoundly stupid” plans for community pharmacy
Community pharmacists must work together to fight government plans to cut community pharmacy funding, a group of 400 pharmacists were told yesterday.
Read MoreHealth leaders set out nine ‘must do’ targets for NHS
Balancing the books, reducing waiting times and new plans for a sustainable general practice are among nine ‘must-do’ targets set out in NHS guidance for the next six years.
Read MoreIMI to focus on Ebola, childhood cancers, neurological disorders and eye disease
The world’s largest public-private partnership in life sciences, the Innovative Medicines Initiative (IMI), has launched two new ‘calls for proposals’, offering stakeholders from a variety of sectors the opportunity to take part in scientifically excellent, patient-centric research.
Read MoreNew ‘nectar-like’ oral formulation for vital ALS drug
The launch of the first liquid form of Martindale’s Teglutik (riluzole) has been welcomed by healthcare professionals as a “great benefit” for patients with motor neurone disease (MND).
Read More- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
